Several studies have shown that metformin and TMZ co-administration leads to a synergic response by glioblastoma cells, with an increase in mortality both in sensitive (with hypermethylated MGMT promoter) and in resistant cells to TMZ [61,99,100]. The gene discussed is MGMT; the disease is glioblastoma.